Since the discovery of the DNA double helix structure, many scientific research efforts have focussed on deciphering the genetic instructions (genes) contained in the genome, their regulation during development and cellular differentiation, and their contribution in the development of disease.
However, an unexpected role has recently been discovered in this process for chromatin. Chromatin is a complex formed by the DNA sequence and histones, proteins that tightly pack DNA into the chromosomes and condition gene expression. The histones “cover the genetic information contained in the DNA and regulate its expression,” explains Ferran Azorín, scientist at the Institute for Research in Biomedicine (IRB Barcelona). Azorín and Tony Kouzarides, director of the Gurdon Institute (United Kingdom), are joint organizers of a Barcelona BioMed conference on chromatin, to be held at IRB Barcelona on March 26-28, 2007, with the collaboration of the BBVA Foundation. (1)
The epigenetic code
Histones hold the set of instructions by which the chromatin regulates the expression of the genetic information written into the DNA. The epigenetic code can be described as “the regulatory information that is not contained in DNA,” explains Azorín. This extra layer of instructions affects genetic activity without altering the DNA sequence. Consequently, outcomes may vary in spite the fact that the genes are the same.
The best example of this is identical twins, who share the same genes and who, in spite of this genetic similarity, will not always develop the same diseases. If the epigenetic code differs, the same gene can be activated or silenced. Epigenetic information has often been compared to the keynote in which a musical score is played: for the same set of notes, the result varies depending on the keynote. These epigenetic instructions comprise what is known as the epigenome.
Epigenetics and cancer
Alterations in the epigenome can trigger the development of diseases, like some forms of cancer or Angelman and Rett syndromes. “Deciphering the epigenome will help clarify fundamental aspects of the cellular physiology, thereby enhancing our understanding of the development of these diseases, and possibly leading to new cures,” remarks Azorín. A new family of 'epigenetic' drugs, designed to revert changes in the epigenome that occur during the development of several types of cancer, is now available. Some, like the DNA demethylation compounds and histones deacetylases (HDAC) inhibitors, are already being used to treat some types of leukemias and breast cancers.
The influence of the environment
The epigenome can also provide valuable insight into the influence that environment has on genetic activity. The physical differences observed between identical twins are due mostly to epigenetic factors, explains Azorín. These differences, which may be the result of environmental factors, appear to account for the differing susceptibility of each twin to develop disease. International studies are currently being conducted to determine the role of epigenetics in the development of disease. For example, the Wellcome Trust Sanger Institute, member of the Human Epigenome Project (HEP) consortium (2), has carried out an international study on a cohort of twins who present differences in the development of type 1 diabetes. Their aim is to identify the epigenetic differences that explain why only one of the twins develops the disease (3). Other studies report that the presence of certain micronutrients, like folic acid or vitamin B12, in the diet of pregnant rats provokes epigenetic modifications that alter the expression of specific genes (4).
The epigenetics 'boom'
“Recent years have witnessed a true explosion in this field,” says Azorín. “Scientific magazines publish new results daily”. Expectations are high: epigenetic studies promise not only to have a direct impact on health and on our understanding of the relationship between environmental factors and genetics, but also to provide a better explanation of basic aspects of cell biology.
“Histones,” explains Azorín, “are extraordinarily well preserved proteins and over evolution have conferred upon chromatin some very crucial functions.” They are involved in essential processes during development and cellular differentiation such as, for example, the 'cellular memory' with which the progeny of a cell 'remember' the epigenetic state of essential genes in the stem cell in order to maintain a differentiated state.
Another example of the role of histones is a phenomenon called dosage compensation. In mammals, males have one X-chromosome, while females have two. Females therefore have twice the number of genes found on the X chromosome. Chromatin silences one of the two female X chromosomes throughout the development, and in doing so, compensates for the excess. A similar phenomenon occurs in several insect species, although, in this case, chromatin determines that the X-chromosome of males is twice as active.
The group led by Azorín studies the presence of specific histones in several regions of the chromosome and their role in fundamental cell activities, such as chromosome segregation during the cell division (5). “During cell division, the correct segregation of chromosomes among daughter cells depends mostly on a particular chromosomal structure, called the centromere,” he explains. The DNA sequence is not preserved in centromeres and differs significantly between species – even among chromosomes of the same species.
“Chromatin is the fundamental element of the centromere” explains Azorín. “The centromere contains a specific histone not found in the rest of the chromosome. This characteristic has been preserved during evolution, from yeasts to humans.” But what is the function of this histone? “We know that it’s crucial for the centromere, but we don’t know exactly how it works yet.” They have observed, however, that when the histone is located in other parts of the chromosome it is quickly degraded. This degradation mechanism ensures that this histone occurs exclusively in the centromere.
An exciting future
In spite of breakthroughs in recent years, “we are still far from knowing everything that the epigenetic code implies” observes Azorín. “We learned of the regulatory role of chromatin and histones only ten years ago. Much work remains to be done.”
It is known that the epigenetic information is crucial for the correct function of genes and that each cell type has a characteristic epigenome, which changes during development and the cell cycle. Likewise, in the same cell, epigenetic information differs in distinct regions of the genome.
“For example, when new genes are introduced into the DNA of a cell,” explains Azorín, “they usually fit themselves almost randomly into any region of the genome and, very frequently, end up silencing themselves. This is because they lack chromatin, or 'epigenetic' environment, which usually accompanies them.” This observation poses a challenge for gene therapies that seek to rectify the absence of specific genes or their incorrect functioning through the introduction of functional copies of the same genes. On the other hand, the generation and use of stem cells also requires the capacity to erase 'old' epigenetic instructions and to print 'new' instructions, in an efficient and controlled way.
In short, researchers have a global perspective: they know that each gene is in a specific epigenetic 'environment' that regulates its correct expression. However, many details are still missing. How is the epigenetic environment established and regulated? How is the epigenetic code read? How is the epigenetic code inherited? How it is it erased? In the field of epigenetics, “coming years are guaranteed to be as exciting as recent ones,” affirms Azorín.
(1) Barcelona BioMed Conference on The Regulation of Chromatin Functions. Barcelona, Spain, 26 - 28 March 2007.
(3) Rakyan VK et al. DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project. PLoS Biol. 2004
(4) Weaver et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci. 2005 Nov 23;25(47):11045-54.
(5) O. Moreno-Moreno, M. Torras-Lort and F. Azorín. Proteolysis restricts localisation of CID, the centromere-specific histone H3 variant of Drosophila, to centromeres. Nucleic Acid Res., (advance on-line publication) (7 Nov 2006)
About IRB Barcelona
Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 28 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).